Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study

BackgroundCeftazidime-avibactam is a treatment option for carbapenem-resistant gram-negative bacilli (CR-GNB) infections. However, the risk factors associated with ceftazidime-avibactam (CAZ-AVI) treatment failure in kidney transplant (KT) recipients and the need for CAZ-AVI-based combination therap...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Fei Zhang, Pengfei Li, Jinbiao Zhong, Handong Ding, Guiyi Liao, Chaozhao Liang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2024-05-01
Reeks:	Frontiers in Cellular and Infection Microbiology
Onderwerpen:	Carbapenem-resistant gram-negative bacilli ceftazidime-avibactam kidney transplant infections carbapenem-resistant Klebsiella pneumoniae
Online toegang:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1404404/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!